Development of an immunobiosensor assay for the beta-adrenergic compound zilpaterol

W.L. Shelver, Y.S. Keum, Q.X. Li, Terence Fodey, Christopher Elliott

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


A surface plasmon resonance biosensor method was developed to measure zilpaterol residues in sheep urine. A CM-5 sensor chip previously reacted with ethylenediamine to produce an aminoethyl group was coupled with 4-carboxybutyl zilpaterol activated using EDC/NHS. Five polyclonal and four monoclonal antibodies were screened for their suitability to detect low levels of zilpaterol using the biosensor technology. Total binding was greater for polyclonal than monoclonal antibodies, but a less diluted antibody solution was required for polyclonal antibodies. A fixed antibody concentration and various concentrations of zilpaterol were injected to obtain a standard curve for each antibody to allow for B-0 and IC50 determination. The stability of the assay was assessed by the consistency of B0 in repeated experiments extending at least six hours. A measure of non-specific binding allowed the assessment of the specificity of the antibody-immobilized ligand interaction. The effect of varying concentrations of urine on B-0 and IC50 was evaluated to assess the degree of
Original languageEnglish
Pages (from-to)199-211
Number of pages13
Issue number3
Publication statusPublished - Sep 2005

ASJC Scopus subject areas

  • Food Science
  • Chemistry (miscellaneous)
  • Health, Toxicology and Mutagenesis
  • Immunology
  • Toxicology


Dive into the research topics of 'Development of an immunobiosensor assay for the beta-adrenergic compound zilpaterol'. Together they form a unique fingerprint.

Cite this